CLINICAL_TRIALS
trial_result
· 2024-12-09
Clinical Trial Update: Roflumilast in Non-CF Bronchiectasis Study (2019) [Phase 2]
Summary
Phase 2 study of roflumilast for non-cystic fibrosis bronchiectasis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Hong Kong | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 2 | Status: COMPLETED